Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07402226 · ClinicalTrials.gov registry record · NA
Systemic Sclerosis DIet for GastrointESTinal Symptoms
A NA study, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07402226 is a NA study that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 60 participants.
The verdict
NCT07402226, a NA study, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This research will evaluate the effect of diets on bloating/distention, assess changes in abdominal pain, and overall gastrointestinal symptom burden in Systemic Sclerosis. The researchers will do this by comparing outcomes of people assigned to 3 different diets. Following the research specifics of the diets will be available upon contact with the details listed below.
Interventions
- BEHAVIORAL Diet 1: Restriction of fermentable carbohydrates
- BEHAVIORAL Diet 2: Elimination of foods harmful to gut barrier and microbiome
- BEHAVIORAL Diet 3: Regular meal patterns, soluble fiber, and portion control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-03-16 |
| Est. Completion | 2027-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07402226
The ClinicalTrials.gov registry entry for NCT07402226 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Diet 1: Restriction of fermentable carbohydrates is the first listed.
NCT07402226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07402226 about?
NCT07402226 is a clinical study titled "Systemic Sclerosis DIet for GastrointESTinal Symptoms". This research will evaluate the effect of diets on bloating/distention, assess changes in abdominal pain, and overall gastrointestinal symptom burden in Systemic Sclerosis. The researchers will do this by comparing outcomes of people assigned to 3 different diets. Following the research specifics of...
What is the current status of trial NCT07402226?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-03-16. Estimated completion is 2027-04.
What interventions are being tested in trial NCT07402226?
The interventions under investigation include: Diet 1: Restriction of fermentable carbohydrates (BEHAVIORAL), Diet 2: Elimination of foods harmful to gut barrier and microbiome (BEHAVIORAL), Diet 3: Regular meal patterns, soluble fiber, and portion control (BEHAVIORAL).
Who is sponsoring clinical trial NCT07402226?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.